Clinical Trials Logo

Filter by:
NCT ID: NCT06122467 Completed - Acne Clinical Trials

A Single Group Study to Evaluate the Efficacy of a Cosmetic Product Line on Acne Symptoms

Start date: October 2, 2023
Phase: N/A
Study type: Interventional

This twelve-week trial will examine the effectiveness of a Menning Labs EQ Product Line acne product. Participants will use the exfoliating cleanser, cream, and gel daily for 8 weeks. Participants will complete questionnaires at Baseline, Day 1, Day 3, Day 7, Day 28, Day 42, and Day 56. Participants will also provide before-and-after photos at Baseline, Day 7, and Day 42, as well as undergo expert skin grading at Baseline and Day 42. The questionnaire on Day 56 will mark the conclusion of the trial.

NCT ID: NCT06122376 Completed - Clinical trials for Plaque Induced Gingivitis

Plaque and Gingivitis Evaluation of a U-Shaped Toothbrush in a 30-Day Model

Start date: May 31, 2023
Phase: N/A
Study type: Interventional

The objective of this 30 day, randomized, two group, parallel, examiner-blind clinical trial is to assess the safety and efficacy of AutoBrush® 360° U-shaped Sonic Toothbrush on plaque and gingivitis, compared to an American Dental Association (ADA) reference manual soft toothbrush. The extent of gingival abrasion and recession and oral safety will be evaluated.

NCT ID: NCT06122038 Completed - Inflammation Clinical Trials

Impact of Powdered Tart Cherries on Recovery From Repeated Sprints

TCR
Start date: April 25, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate changes in force and power production, soreness, inflammation, and oxidative stress after repeated sprinting activity and powdered tart cherry ingestion in trained males and females.

NCT ID: NCT06121869 Completed - Hypertrophy Clinical Trials

Dileucine and Resistance Training Adaptations

DTS
Start date: May 7, 2021
Phase: N/A
Study type: Interventional

This study seeks to compare the observed changes in resistance training adaptations after supplementation of isomolar amounts of leucine or dileucine in healthy resistance-trained men. This will provide a better understanding of supplementation with leucine versus dileucine over a 10-week period in regards to increasing muscular performance.

NCT ID: NCT06121193 Completed - Obesity Clinical Trials

Using Interventional Informatics to Address Social Determinants of Health During Clinical Care Visits to Promote Behavior Change and PREVENT Cardiovascular Disease

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Healthcare providers recognize the need for behavior change and the influence of social determinants on youth at risk for poor cardiovascular health (CVH), especially among those of low-socioeconomic status (SES). Yet, providers lack the time and community data necessary to provide tailored, evidence-based care within routine practice. This project will use an Interventional Informatics approach to help providers prescribe patient-centered, evidence-based physical activity and nutrition prescriptions and link patients to community resources to account for social determinants at the point-of-care. This project will integrate our existing, novel, Patient-centered Real-timE interVENTion (PREVENT) tool into the BJC electronic health record (EHR) and test it with providers and adolescent patients at-risk for poor CVH. EHR integration of PREVENT will enable a cyclical, synergistic and data-centric approach to impact modifiable risk factors (physical activity and food intake) and prevent cardiovascular disease. This approach uses health informatics technology (HIT) to deliver data-driven, patient-centered care and generate evidence to support the use of HIT as a way to prevent cardiovascular disease across diverse patients and communities.

NCT ID: NCT06120933 Completed - Hair Loss Clinical Trials

A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair Health

Start date: June 15, 2023
Phase: N/A
Study type: Interventional

This clinical trial aims to investigate the effectiveness of two Vitamins Revive hair supplements in promoting hair growth, reducing hair loss, and improving overall hair health. The products under assessment are Hair Nutra Growth and Hair Nutra Boost. The trial will assess the efficacy of the products to induce better hair growth, reduction in hair loss and shedding, increased hair thickness and fullness, and improvement in hair appearance and vitality over a 12-week testing period. Participants will complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12. Participants will also provide photos of their hair at Baseline, Week 4, Week 8, and Week 12.

NCT ID: NCT06120777 Completed - Healthy Clinical Trials

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.

NCT ID: NCT06119191 Completed - Myopia Clinical Trials

Clinical Evaluation of Reusable Soft Contact Lenses

Start date: November 14, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to confirm the clinical performance of a novel manufacturing process for comfilcon A contact lenses in habitual wearers.

NCT ID: NCT06119165 Completed - Healthy Diet Clinical Trials

Impact of Environmental Nudges on Dietary Quality

Start date: November 28, 2023
Phase: N/A
Study type: Interventional

Purpose: The overall purpose of this study is to evaluate the impact of a suite of environmentally focused nudges on the nutritional quality of consumers' food selections. Participants: ~2,000 US adults ages 18-25, at least 25% currently enrolled full-time in college, recruited from CloudResearch Prime Panels. Procedures: Participants will be randomly assigned to view food products with or without environmental nudges (eco-labels, peer comparison message, and swaps). They will be asked to select items that they most wish to purchase and will then be asked a series of questions about the products and nudges. Questions will also include standard socio-demographic variables.

NCT ID: NCT06118151 Completed - Influenza Clinical Trials

Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older

Start date: April 11, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and immunogenicity of a single intramuscular (IM) injection of different dose levels of messenger ribonucleic acid (mRNA) vaccine encoding influenza hemagglutinin compared to an active control quadrivalent recombinant influenza vaccine (RIV4) in adults 18 years of age and older. Study details include: Study Duration: approximately 6 months Treatment Duration: 1 injection of mRNA vaccine encoding influenza hemagglutinin encoding influenza hemagglutinin or control. Visit Frequency: Screening visit, Day 01, Day 02, Day 03, Day 09, Day 29, Day 91, Day 181